iSpecimen (NASDAQ:ISPC – Get Free Report) will be posting its quarterly earnings results before the market opens on Tuesday, May 7th. Individual interested in registering for the company’s earnings conference call can do so using this link.
iSpecimen (NASDAQ:ISPC – Get Free Report) last released its quarterly earnings results on Wednesday, March 13th. The company reported ($0.34) earnings per share for the quarter. iSpecimen had a negative return on equity of 80.37% and a negative net margin of 111.81%. The company had revenue of $2.58 million for the quarter.
iSpecimen Stock Up 1.5 %
Shares of NASDAQ:ISPC traded up $0.00 on Tuesday, hitting $0.30. The company had a trading volume of 111,890 shares, compared to its average volume of 656,717. The business has a 50 day moving average of $0.33 and a 200 day moving average of $0.45. iSpecimen has a 52-week low of $0.20 and a 52-week high of $1.89.
iSpecimen Company Profile
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
Read More
- Five stocks we like better than iSpecimen
- 5 discounted opportunities for dividend growth investors
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Hilton Demonstrates Asset Light is Right for Investors
- How to Start Investing in Real Estate
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
